Выходит 6 номеров в год
ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X
Indexed in
Steroid Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Краткое описание
The targeted delivery of chemotherapeutics is essential to minimizing the side effects by sparing the normal tissues by exposure to cytotoxic agents. The various receptors are overexpressed on the surface of the tumor tissues as compared to the normal tissues because their requirement for various essential components is high for the growth and development of tumor tissues. These overexpressed receptors on the tumor surface have been investigated for selective delivery of imaging, cytotoxic, or other therapeutic agents. Hormonal receptors viz. peptide and steroid receptors (SRs), which are present over the tumor surface, are also used for tumor targeting of various molecules for therapeutic use or imaging purpose. The key role of SRs is in the transactivation step of protein synthesis and to maintain the homeostasis in normal and diseased states. These receptors are overactivated in different diseases, including tumorigenesis. Hence, these SRs may act as a potential target for selective delivery of different therapeutic or cytotoxic agents. The selective delivery of these agents may be a better treatment strategy for endocrine cancer because it results in cytosolic and nuclear delivery of cytotoxic agents as well. The objective of the present review is to explore the importance of sex SRs as a vital target in endocrine cancer therapy. Potential strategies investigated for the delivery of imaging agents, chemotherapeutics, and toxins via steroidal ligands have been discussed. The importance of gene therapy in different diseases, including endocrine cancer, is well defined; thus, some effective gene delivery approaches investigated in endocrine cancer via steroidal ligands have also been discussed.
-
Zhang Yi, Shi Wei, Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling, Biochemistry and Cell Biology, 97, 4, 2019. Crossref
-
Wängler Björn, Schirrmacher Ralf, Wängler Carmen, Aiming at the tumor-specific accumulation of MGMT-inhibitors: First description of a synthetic strategy towards inhibitor-peptide conjugates, Tetrahedron Letters, 61, 19, 2020. Crossref
-
Stuckey Ashley, Fischer Andrew, Miller Daniel H, Hillenmeyer Sara, Kim Kyu K, Ritz Anna, Singh Rakesh K, Raphael Benjamin J, Brard Laurent, Brodsky Alexander S, Integrated genomics of ovarian xenograft tumor progression and chemotherapy response, BMC Cancer, 11, 1, 2011. Crossref
-
Jain Sanjay K, Jain Ashish, Gulbake Arvind, Shilpi Satish, Khare Piush, Steroid-coupled liposomes for targeted delivery to tumor, Therapeutic Delivery, 1, 2, 2010. Crossref